What's new? Log in Free sign up

Spectral AI (MDAI)

Company Profile

Company profile

Ticker

MDAI, MDAIW

Exchange

Website

www.spectral-ai.com

CEO

Mr. Wensheng Fan

Incorporated

Location

Fiscal year end

Sector

Health Care and Social Assistance > Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Ares Capital • Becton, Dickinson and • Stryker • Boston Scientific • Solventum • Baxter International • Teleflex • Hercules Capital • ResMed ...

Former names

Rosecliff Acquisition Corp I

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries

Spectral MD, Inc. • Spectral MD Holdings LLC • Spectral MD UK Limited • Spectral Deepview Limited ...

MDAI stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements

Prospectus supplement for primary offering

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

Prospectus supplement for primary offering

Prospectus supplement

Notice of effectiveness

Shelf registration

21 Nov 24

Prospectus supplement for primary offering

Quarterly report

6 Nov 24

Notice of effectiveness

Transcripts

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Octopus Investments Ltd.

ERICH SPANGENBERG

John Michael DiMaio

Vincent S. Capone

Peter M Carlson

ERICH SPANGENBERG

Jeremiah A. Sparks

HIRSCH LAURENCE E

DiMaio John Michael

Financial summary

Financial statements Chart MDAI financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	3.70 mm	3.70 mm	3.70 mm	3.70 mm	3.70 mm	3.70 mm
Cash burn (monthly)	1.06 mm	303.83 k	489.00 k	917.67 k	542.00 k	1.00 mm
Cash used (since last report)	4.64 mm	1.33 mm	2.14 mm	4.02 mm	2.38 mm	4.40 mm
Cash remaining	-937.87 k	2.37 mm	1.56 mm	-321.17 k	1.33 mm	-697.84 k
Runway (months of cash)	-0.9	7.8	3.2	-0.3	2.4	-0.7

Beta Read what these cash burn values mean

Financial data from Spectral AI earnings reports.

Institutional ownership, Q3 2024

MDAI institutional ownership history Ownership history

48.9% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	36	26	+38.5%
Opened positions	17	1	+1600.0%
Closed positions	7	1	+600.0%
Increased positions	3	1	+200.0%
Reduced positions	0	1	EXIT

13F shares	Current	Prev Q	Change
Total value	3.61 bn	269.98 mm	+1237.5%
Total shares	10.39 mm	8.53 mm	+21.7%
Total puts	0.00	0.00
Total calls	129.10 k	185.10 k	-30.3%
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Erich Spangenberg	4.16 mm	$10.40 mm	0.0%
Octopus Investments	960.21 k	$2.79 mm	0.0%
Laurence E Hirsch	900.00 k	$1.91 mm	0.0%
Highlander Partners	900.00 k	$1.28 bn	NEW
SF Stifel Financial	758.58 k	$804.10 mm	NEW
RAT Rathbone Brothers	436.12 k	$462.29 mm	NEW
Cowen And	360.38 k	$45.05 mm	+32.8%
Q Global Advisors	211.79 k	$26.00 k	0.0%
University Of Texas/texas Am Investment Managment	210.49 k	$223.12 mm	NEW
Balyasny Asset Management	190.32 k	$24.02 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Highlander Partners	900.00 k	+900.00 k	NEW
Clear Street Derivatives	0.00	-759.55 k	EXIT
SF Stifel Financial	758.58 k	+758.58 k	NEW
RAT Rathbone Brothers	436.12 k	+436.12 k	NEW
University Of Texas/texas Am Investment Managment	210.49 k	+210.49 k	NEW
Honkamp Krueger Financial Services	159.85 k	+159.85 k	NEW
Aristeia Capital	0.00	-140.66 k	EXIT
Vanguard	105.40 k	+105.40 k	NEW
Kim	0.00	-100.00 k	EXIT
Geode Capital Management	96.74 k	+96.74 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

MDAI insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 May 24	Erich Spangenberg	Common Stock	Grant	Acquire A	No	No	1.74	6,000	10.44 k	628,574
10 May 24	Erich Spangenberg	Common Stock	Grant	Acquire A	No	No	1.77	45,000	79.65 k	622,574
10 May 24	Carlson Peter M	Common Stock	Grant	Acquire A	No	No	1.74	29,411	51.18 k	29,411
10 May 24	Jeremiah A. Sparks	Common Stock	Grant	Acquire A	No	No	1.65	6,084	10.04 k	16,084
10 May 24	Vincent S. Capone	Common Stock	Grant	Acquire A	No	No	1.73	10,000	17.30 k	19,700

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Spectral AI Completes Pediatric Enrollment In Emergency Departments For U.S. Burn Pivotal Study; Company Will Pursue A De Novo Classification From The U.S. FDA For Use Of The DeepView System And Expects To Submit The Request In The First Half Of 2025

Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in 2018, that uses multi-spectral imaging and

Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket

Spectral AI Announces The Successful Completion Of An ~$5M Equity Financing In An At-The-Market Transaction, Strengthening Financial Position For FDA Pathway

Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care,

Press releases

From Benzinga Pro

Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study

DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food

Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study

DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA

Spectral AI Provides Update to Investors

DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA

Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants

Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.